REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE QUNTIFICATION OF CEFOTAXIME SODIUM IN PHARMACEUTICAL DOSAGE FORM
Abstract
A simple, sensitive, fast & precise Reverse Phase High Performance Liquid Chromatographic method was developed for the determination of Cefotaxime Sodium in pharmaceutical dosage form. The RP-HPLC separation was achieved on hypersil C18 column (250 mm, 4.6 mm, 5µm) using mobile phase consisting of buffer solution (sodium dihydrogen phosphate) : acetonitrile  [37: 63 v/v, pH=2.75 adjusted with phosphoric acid] at a flow rate of 1ml/min and the retention time was about 6 minutes. The method is selective to Cefotaxime Sodium and able to resolve the drug peak from formulation excipients. The system suitability with retention time was (Mean + %CV) 8.600 + 0.186.The calibration curve was linear over the concentration range of 1-20µg/ml (r2 = 0.999). The proposed method is accurate and precise (Intra day and Inter day variation, RSD were 0.55-1.67) and linear within the desired range. The LOD and LOQ was detected as 0.0187µg/ml and 0.043µg/ml respectively with r2 = 0.9997. The accuracy result of seventy percent drug (80%) was 99.87%, hundred percent (100%) was 99.93%, and one thirty percent (120%) was 100.18%. Therefore, this method could be used as a more convenient and efficient option for the analysis of Cefotaxime Sodium in raw material and Parentral dosage form.
Keywords:   Third   generation   cephalosporin;   Cefotaxime Sodium;   Method   validation;   HPLC   method determination; Quantitative analysis
DOI
https://doi.org/10.22270/jddt.v5i3.1154Published
Abstract Display: 406 
PDF Downloads: 730 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.